Telmisartan 80mg Non-responder Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.

Also called NCT01222520

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 174 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01222520
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01222520. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-06 (actual). Results posted on 2012-07-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Telmisartan 80mg Non-responder Trial
Condition
Hypertension
Intervention (Drug)
Telmisartan and amlodipine
Intervention (Drug)
Telmisartan
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct01222520
Content hash
2edfd434ad6959e59c94d4d08a5b14d68d208fb531fa0325c035113348275d21